BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32581204)

  • 1. [Therapeutic Response to 20 mg of Esomeprazole Twice Daily in Patients with Gastroesophageal Reflux Disease-related Non-cardiac Chest Pain: An Open-Label Randomized Pilot Study].
    Choi JK; Shim HI; Shin CM; Yoon H; Park YS; Kim N; Lee DH
    Korean J Gastroenterol; 2020 Jun; 75(6):333-340. PubMed ID: 32581204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What is the utility of proton pump inhibitor testing in non-cardiac chest pain?].
    Huamán JW; Aliaga V; Domenech G; Videla S; Saperas E
    Gastroenterol Hepatol; 2014 Oct; 37(8):452-61. PubMed ID: 24725608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
    Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients.
    Kim JH; Sinn DH; Son HJ; Kim JJ; Rhee JC; Rhee PL
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1504-9. PubMed ID: 19467139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan.
    Sakurai K; Suda H; Fujie S; Takeichi T; Okuda A; Murao T; Hasuda K; Hirano M; Ito K; Tsuruta K; Hattori M
    Dig Dis Sci; 2019 Mar; 64(3):815-822. PubMed ID: 30415407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
    Davidson G; Wenzl TG; Thomson M; Omari T; Barker P; Lundborg P; Illueca M
    J Pediatr; 2013 Sep; 163(3):692-8.e1-2. PubMed ID: 23800403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease.
    Williams JF; Sontag SJ; Schnell T; Leya J
    Am J Gastroenterol; 2009 Sep; 104(9):2145-52. PubMed ID: 19513020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life.
    Takeshima F; Hashiguchi K; Onitsuka Y; Tanigawa K; Minami H; Matsushima K; Akazawa Y; Shiozawa K; Yamaguchi N; Taura N; Ohnita K; Ichikawa T; Isomoto H; Nakao K
    Med Sci Monit; 2015 Dec; 21():4111-21. PubMed ID: 26719012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain.
    Dekel R; Martinez-Hawthorne SD; Guillen RJ; Fass R
    J Clin Gastroenterol; 2004 Jan; 38(1):24-9. PubMed ID: 14679323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Postprandial Administration of Esomeprazole on Reflux Symptoms in Gastroesophageal Reflux Disease: A Randomized, Controlled Trial.
    Boltin D; Zvidi I; Raskin M; Kayless H; Schmilovitz-Weiss H; Gingold-Belfer R; Niv Y; Dickman R
    Dig Dis; 2018; 36(4):257-263. PubMed ID: 29791895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncardiac chest pain: diagnosis and management.
    Yamasaki T; Fass R
    Curr Opin Gastroenterol; 2017 Jul; 33(4):293-300. PubMed ID: 28463855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy.
    Hatlebakk JG; Zerbib F; Bruley des Varannes S; Attwood SE; Ell C; Fiocca R; Galmiche JP; Eklund S; Långström G; Lind T; Lundell LR;
    Clin Gastroenterol Hepatol; 2016 May; 14(5):678-85.e3. PubMed ID: 26226096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Noncardiac chest pain and gastroesophageal reflux disease].
    Dimache M; Turcan E; Nătase M
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):342-8. PubMed ID: 20700964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.
    Vasiliadis KV; Viazis N; Vlachogiannakos J; Sgouros SN; Stefanidis G; Archimandritis A; Karamanolis DG
    Am J Gastroenterol; 2010 Feb; 105(2):308-13. PubMed ID: 19809412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
    Namikoshi T; Harada K; Hatta H; Tokura T; Oshiro Y; Nishizaki T; Obata T; Mori M; Fueki T; Fujimoto S; Haruna Y; Kuwabara A; Yorimitsu D; Ihoriya C; Kadoya H; Itano S; Fujimoto Y; Komai N; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2016 Feb; 20(1):134-42. PubMed ID: 26026991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncardiac chest pain: update on the diagnosis and management.
    Min YW; Rhee PL
    Korean J Gastroenterol; 2015 Feb; 65(2):76-84. PubMed ID: 25716709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review: the treatment of noncardiac chest pain.
    Hershcovici T; Achem SR; Jha LK; Fass R
    Aliment Pharmacol Ther; 2012 Jan; 35(1):5-14. PubMed ID: 22077344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain.
    Viazis N; Katopodi K; Karamanolis G; Denaxas K; Varytimiadis L; Galanopoulos M; Tsoukali E; Kamberoglou D; Christidou A; Karamanolis DG; Papatheodoridis G; Mantzaris GJ
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1054-1058. PubMed ID: 28628496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost analysis of long-term treatment of patients with symptomatic gastroesophageal reflux disease (GERD) with esomeprazole on-demand treatment or esomeprazole continuous treatment: an open, randomized, multicenter study in Switzerland.
    Szucs T; Thalmann C; Michetti P; Beglinger C
    Value Health; 2009; 12(2):273-81. PubMed ID: 18783388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.